Format

Send to

Choose Destination
Climacteric. 2015 Oct;18(5):757-63. doi: 10.3109/13697137.2015.1045485.

Vaginal erbium laser: the second-generation thermotherapy for the genitourinary syndrome of menopause.

Author information

1
a * Department of Obstetrics and Gynecology , Pisa University Hospital , Pisa , Italy.
2
b Department of Obstetrics and Gynecology , Clinica Alemana, Universidad Del Desarrollo , Santiago , Chile.
3
c Department of Obstetrics and Gynecology , Catholic University of the Sacred Heart , Rome , Italy.

Abstract

Aim To evaluate the effects of the vaginal erbium laser (VEL) in the treatment of postmenopausal women suffering from genitourinary syndrome of menopause (GSM). Method GSM was assessed in postmenopausal women before and after VEL (one treatment every 30 days, for 3 months; n = 45); the results were compared with the effects of a standard treatment for GSM (1 g of vaginal gel containing 50 μg of estriol, twice weekly for 3 months; n = 25). GSM was evaluated with subjective (visual analog scale, VAS) and objective (Vaginal Health Index Score, VHIS) measures. In addition, in 19 of these postmenopausal women suffering from stress urinary incontinence (SUI), the degree of incontinence was evaluated with the International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form (ICIQ-UI SF) before and after VEL treatments. Results VEL treatment induced a significant decrease of VAS of both vaginal dryness and dyspareunia (p < 0.01), with a significant (p < 0.01) increase of VHIS. In postmenopausal women suffering from mild to moderate SUI, VEL treatment was associated with a significant (p < 0.01) improvement of ICIQ-SF scores. The effects were rapid and long lasting, up to the 24th week of the observation period. VEL was well tolerated with less than 3% of patients discontinuing treatment due to adverse events. Conclusion This pilot study demonstrates that VEL induces a significant improvement of GSM, including vaginal dryness, dyspareunia and mild to moderate SUI. Further studies are needed to explore the role of laser treatments in the management of GSM.

KEYWORDS:

DYSPAREUNIA; ERBIUM LASER; GENITOURINARY SYNDROME OF MENOPAUSE; MENOPAUSE; STRESS URINARY INCONTINENCE; VAGINAL ATROPHY

Comment in

PMID:
26029987
PMCID:
PMC4673600
DOI:
10.3109/13697137.2015.1045485
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Taylor & Francis Icon for PubMed Central
Loading ...
Support Center